Skip to main content
Erschienen in: Journal of Assisted Reproduction and Genetics 6/2020

22.04.2020 | Embryo Biology

Unbalanced human embryos secrete more hyperglycosylated human chorionic gonadotrophin (hCG-H) than balanced ones

verfasst von: Dimitar Parvanov, Dragomira Nikolova, Rumiana Ganeva, Kristina Nikolova, Magdalena Vasileva, Ivaylo Rangelov, Maria Pancheva, Maria Serafimova, Rada Staneva, Savina Hadjidekova, Fabio Scarpellini, Georgi Stamenov

Erschienen in: Journal of Assisted Reproduction and Genetics | Ausgabe 6/2020

Einloggen, um Zugang zu erhalten

Abstract

Purpose

The aim of this study was to compare the levels of hyperglycosylated human chorionic gonadotropin (hCG-H) secreted from balanced and unbalanced human embryos.

Methods

Single-step culture media samples from 155 good quality embryos, derived from 90 good prognosis patients undergoing intracytoplasmic sperm injection (ICSI), were collected on the fifth day of embryo cultivation. All embryos were tested by next-generation sequencing (NGS) technique. The hCG-H levels in the culture media were evaluated by ELISA kit (Cusabio Biotech, CBS-E15803h) according to the manufacturer’s instructions. Statistical analysis was performed using SPSS v.21 (IBM Corp., Armonk, NY, USA).

Results

The NGS analysis revealed that 36% of the embryos (n = 56) were balanced, and 64% of the embryos were unbalanced (n = 99). The presence of hCG-H was confirmed in all embryo culture media samples but was absent in the negative control. In addition, hCG-H concentration was significantly higher in the culture media from unbalanced embryos compared with the balanced ones (0.72 ± 0.30 mIU/ml vs. 0.62 ± 0.12 mIU/ml, p = 0.02, respectively). Furthermore, the mean levels of hCG-H were significantly increased in the samples from embryos with multiple abnormalities. Finally, the highest levels of hCG-H were expressed from embryos with monosomy of chromosome 11 (1.28 ± 0.04 mIU/ml) and those with trisomies of chromosomes 21 (2.23 mIU/ml) and 4 (1.02 ± 0.35 mIU/ml).

Conclusion

Our results suggest that chromosomal aberrations in human embryos are associated with an increased secretion of hCG-H. However, hCG-H concentration in embryo culture media as a single biomarker is not sufficient for an accurate selection of balanced embryos.
Literatur
1.
Zurück zum Zitat Chavez SL, Loewke KE, Han J, Moussavi F, Colls P, Munne S, et al. Dynamic blastomere behaviour reflects human embryo ploidy by the four-cell stage. Nat Commun. 2012;3:1251.CrossRefPubMed Chavez SL, Loewke KE, Han J, Moussavi F, Colls P, Munne S, et al. Dynamic blastomere behaviour reflects human embryo ploidy by the four-cell stage. Nat Commun. 2012;3:1251.CrossRefPubMed
2.
Zurück zum Zitat Findikli N, Kahraman S, Saglam Y, Beyazyurek C, Sertyel S, Karlikaya G, et al. Embryo aneuploidy screening for repeated implantation failure and unexplained recurrent miscarriage. Reprod BioMed Online. 2006;13(1):38–46.CrossRefPubMed Findikli N, Kahraman S, Saglam Y, Beyazyurek C, Sertyel S, Karlikaya G, et al. Embryo aneuploidy screening for repeated implantation failure and unexplained recurrent miscarriage. Reprod BioMed Online. 2006;13(1):38–46.CrossRefPubMed
3.
Zurück zum Zitat Wang Y, Chen Y, Tian F, Zhang J, Song Z, Wu Y, et al. Maternal mosaicism is a significant contributor to discordant sex chromosomal aneuploidies associated with noninvasive prenatal testing. Clin Chem. 2014;60(1):251–9.CrossRefPubMed Wang Y, Chen Y, Tian F, Zhang J, Song Z, Wu Y, et al. Maternal mosaicism is a significant contributor to discordant sex chromosomal aneuploidies associated with noninvasive prenatal testing. Clin Chem. 2014;60(1):251–9.CrossRefPubMed
4.
Zurück zum Zitat Campbell A, Fishel S, Bowman N, Duffy S, Sedler M, Hickman CF. Modelling a risk classification of aneuploidy in human embryos using non-invasive morphokinetics. Reprod BioMed Online. 2013;26(5):477–85.CrossRefPubMed Campbell A, Fishel S, Bowman N, Duffy S, Sedler M, Hickman CF. Modelling a risk classification of aneuploidy in human embryos using non-invasive morphokinetics. Reprod BioMed Online. 2013;26(5):477–85.CrossRefPubMed
5.
Zurück zum Zitat Hassold T, Hunt P. To err (meiotically) is human: the genesis of human aneuploidy. Nat Rev Genet. 2001;2(4):280–91.CrossRefPubMed Hassold T, Hunt P. To err (meiotically) is human: the genesis of human aneuploidy. Nat Rev Genet. 2001;2(4):280–91.CrossRefPubMed
6.
Zurück zum Zitat Liu L, Li Y, Li S, Hu N, He Y, Pong R, et al. Comparison of next-generation sequencing systems. J Biomed Biotechnol. 2012;2012:251364.PubMedPubMedCentral Liu L, Li Y, Li S, Hu N, He Y, Pong R, et al. Comparison of next-generation sequencing systems. J Biomed Biotechnol. 2012;2012:251364.PubMedPubMedCentral
7.
Zurück zum Zitat Cimadomo D, Capalbo A, Ubaldi FM, Scarica C, Palagiano A, Canipari R, et al. The impact of biopsy on human embryo developmental potential during preimplantation genetic diagnosis. Biomed Res Int. 2016;2016:7193075.CrossRefPubMedPubMedCentral Cimadomo D, Capalbo A, Ubaldi FM, Scarica C, Palagiano A, Canipari R, et al. The impact of biopsy on human embryo developmental potential during preimplantation genetic diagnosis. Biomed Res Int. 2016;2016:7193075.CrossRefPubMedPubMedCentral
8.
9.
Zurück zum Zitat Liang B, Gao Y, Xu J, Song Y, Xuan L, Shi T, et al. Raman profiling of embryo culture medium to identify aneuploid and euploid embryos. Fertil Steril. 2019;111(4):753–62 e1.CrossRefPubMed Liang B, Gao Y, Xu J, Song Y, Xuan L, Shi T, et al. Raman profiling of embryo culture medium to identify aneuploid and euploid embryos. Fertil Steril. 2019;111(4):753–62 e1.CrossRefPubMed
10.
Zurück zum Zitat Butler SA, Luttoo J, Freire MO, Abban TK, Borrelli PT, Iles RK. Human chorionic gonadotropin (hCG) in the secretome of cultured embryos: hyperglycosylated hCG and hCG-free beta subunit are potential markers for infertility management and treatment. Reprod Sci. 2013;20(9):1038–45.CrossRefPubMed Butler SA, Luttoo J, Freire MO, Abban TK, Borrelli PT, Iles RK. Human chorionic gonadotropin (hCG) in the secretome of cultured embryos: hyperglycosylated hCG and hCG-free beta subunit are potential markers for infertility management and treatment. Reprod Sci. 2013;20(9):1038–45.CrossRefPubMed
12.
Zurück zum Zitat Kovalevskaya G, Kakuma T, Schlatterer J, O'Connor JF. Hyperglycosylated HCG expression in pregnancy: cellular origin and clinical applications. Mol Cell Endocrinol. 2007;260-262:237–43.CrossRefPubMed Kovalevskaya G, Kakuma T, Schlatterer J, O'Connor JF. Hyperglycosylated HCG expression in pregnancy: cellular origin and clinical applications. Mol Cell Endocrinol. 2007;260-262:237–43.CrossRefPubMed
13.
Zurück zum Zitat Mock P, Kovalevskaya G, O'Connor JF, Campana A. Choriocarcinoma-like human chorionic gonadotrophin (HCG) and HCG bioactivity during the first trimester of pregnancy. Hum Reprod. 2000;15(10):2209–14.CrossRefPubMed Mock P, Kovalevskaya G, O'Connor JF, Campana A. Choriocarcinoma-like human chorionic gonadotrophin (HCG) and HCG bioactivity during the first trimester of pregnancy. Hum Reprod. 2000;15(10):2209–14.CrossRefPubMed
15.
Zurück zum Zitat Guibourdenche J, Handschuh K, Tsatsaris V, Gerbaud P, Leguy MC, Muller F, et al. Hyperglycosylated hCG is a marker of early human trophoblast invasion. J Clin Endocrinol Metab. 2010;95(10):E240–4.CrossRefPubMed Guibourdenche J, Handschuh K, Tsatsaris V, Gerbaud P, Leguy MC, Muller F, et al. Hyperglycosylated hCG is a marker of early human trophoblast invasion. J Clin Endocrinol Metab. 2010;95(10):E240–4.CrossRefPubMed
16.
Zurück zum Zitat Kajihara T, Uchino S, Suzuki M, Itakura A, Brosens JJ, Ishihara O. Human chorionic gonadotropin confers resistance to oxidative stress-induced apoptosis in decidualizing human endometrial stromal cells. Fertil Steril. 2011;95(4):1302–7.CrossRefPubMed Kajihara T, Uchino S, Suzuki M, Itakura A, Brosens JJ, Ishihara O. Human chorionic gonadotropin confers resistance to oxidative stress-induced apoptosis in decidualizing human endometrial stromal cells. Fertil Steril. 2011;95(4):1302–7.CrossRefPubMed
17.
Zurück zum Zitat Fogle RH, Li A, Paulson RJ. Modulation of HOXA10 and other markers of endometrial receptivity by age and human chorionic gonadotropin in an endometrial explant model. Fertil Steril. 2010;93(4):1255–9.CrossRefPubMed Fogle RH, Li A, Paulson RJ. Modulation of HOXA10 and other markers of endometrial receptivity by age and human chorionic gonadotropin in an endometrial explant model. Fertil Steril. 2010;93(4):1255–9.CrossRefPubMed
18.
Zurück zum Zitat Yang H, Lei CX, Zhang W. Human chorionic gonadotropin (hCG) regulation of galectin-3 expression in endometrial epithelial cells and endometrial stromal cells. Acta Histochem. 2013;115(1):3–7.CrossRefPubMed Yang H, Lei CX, Zhang W. Human chorionic gonadotropin (hCG) regulation of galectin-3 expression in endometrial epithelial cells and endometrial stromal cells. Acta Histochem. 2013;115(1):3–7.CrossRefPubMed
19.
Zurück zum Zitat O'Connor JF, Ellish N, Kakuma T, Schlatterer J, Kovalevskaya G. Differential urinary gonadotrophin profiles in early pregnancy and early pregnancy loss. Prenat Diagn. 1998;18(12):1232–40.CrossRefPubMed O'Connor JF, Ellish N, Kakuma T, Schlatterer J, Kovalevskaya G. Differential urinary gonadotrophin profiles in early pregnancy and early pregnancy loss. Prenat Diagn. 1998;18(12):1232–40.CrossRefPubMed
20.
Zurück zum Zitat Kovalevskaya G, Birken S, Kakuma T, Ozaki N, Sauer M, Lindheim S, et al. Differential expression of human chorionic gonadotropin (hCG) glycosylation isoforms in failing and continuing pregnancies: preliminary characterization of the hyperglycosylated hCG epitope. J Endocrinol. 2002;172(3):497–506.CrossRefPubMed Kovalevskaya G, Birken S, Kakuma T, Ozaki N, Sauer M, Lindheim S, et al. Differential expression of human chorionic gonadotropin (hCG) glycosylation isoforms in failing and continuing pregnancies: preliminary characterization of the hyperglycosylated hCG epitope. J Endocrinol. 2002;172(3):497–506.CrossRefPubMed
21.
Zurück zum Zitat Sutton-Riley JM, Khanlian SA, Byrn FW, Cole LA. A single serum test for measuring early pregnancy outcome with high predictive value. Clin Biochem. 2006;39(7):682–7.CrossRefPubMed Sutton-Riley JM, Khanlian SA, Byrn FW, Cole LA. A single serum test for measuring early pregnancy outcome with high predictive value. Clin Biochem. 2006;39(7):682–7.CrossRefPubMed
22.
Zurück zum Zitat Sasaki Y, Ladner DG, Cole LA. Hyperglycosylated human chorionic gonadotropin and the source of pregnancy failures. Fertil Steril. 2008;89(6):1781–6.CrossRefPubMed Sasaki Y, Ladner DG, Cole LA. Hyperglycosylated human chorionic gonadotropin and the source of pregnancy failures. Fertil Steril. 2008;89(6):1781–6.CrossRefPubMed
23.
Zurück zum Zitat Grossman K, Cordina M, Ross JA. Is there a role for hyperglycosylated hCG in the diagnosis of ectopic pregnancy in women with a pregnancy of unknown location? J Reprod Med. 2017;62(1–2):15–20.PubMed Grossman K, Cordina M, Ross JA. Is there a role for hyperglycosylated hCG in the diagnosis of ectopic pregnancy in women with a pregnancy of unknown location? J Reprod Med. 2017;62(1–2):15–20.PubMed
24.
Zurück zum Zitat Bahado-Singh RO, Oz AU, Kingston JM, Shahabi S, Hsu CD, Cole L. The role of hyperglycosylated hCG in trophoblast invasion and the prediction of subsequent pre-eclampsia. Prenat Diagn. 2002;22(6):478–81.CrossRefPubMed Bahado-Singh RO, Oz AU, Kingston JM, Shahabi S, Hsu CD, Cole L. The role of hyperglycosylated hCG in trophoblast invasion and the prediction of subsequent pre-eclampsia. Prenat Diagn. 2002;22(6):478–81.CrossRefPubMed
25.
Zurück zum Zitat Keikkala E, Koskinen S, Vuorela P, Laivuori H, Romppanen J, Heinonen S, et al. First trimester serum placental growth factor and hyperglycosylated human chorionic gonadotropin are associated with pre-eclampsia: a case control study. BMC Pregnancy Childbirth. 2016;16(1):378.CrossRefPubMedPubMedCentral Keikkala E, Koskinen S, Vuorela P, Laivuori H, Romppanen J, Heinonen S, et al. First trimester serum placental growth factor and hyperglycosylated human chorionic gonadotropin are associated with pre-eclampsia: a case control study. BMC Pregnancy Childbirth. 2016;16(1):378.CrossRefPubMedPubMedCentral
26.
Zurück zum Zitat Cole LA. Proportion hyperglycosylated hCG: a new test for discriminating gestational trophoblastic diseases. Int J Gynecol Cancer. 2014;24(9):1709–14.CrossRefPubMed Cole LA. Proportion hyperglycosylated hCG: a new test for discriminating gestational trophoblastic diseases. Int J Gynecol Cancer. 2014;24(9):1709–14.CrossRefPubMed
27.
Zurück zum Zitat Ramu S, Acacio B, Adamowicz M, Parrett S, Jeyendran RS. Human chorionic gonadotropin from day 2 spent embryo culture media and its relationship to embryo development. Fertil Steril. 2011;96(3):615–7.CrossRefPubMed Ramu S, Acacio B, Adamowicz M, Parrett S, Jeyendran RS. Human chorionic gonadotropin from day 2 spent embryo culture media and its relationship to embryo development. Fertil Steril. 2011;96(3):615–7.CrossRefPubMed
28.
Zurück zum Zitat Xiao-Yan C, Jie L, Dang J, Tao L, Xin-Ru L, Guang-Lun Z. A highly sensitive electrochemiluminescence immunoassay for detecting human embryonic human chorionic gonadotropin in spent embryo culture media during IVF-ET cycle. J Assist Reprod Genet. 2013;30(3):377–82.CrossRefPubMed Xiao-Yan C, Jie L, Dang J, Tao L, Xin-Ru L, Guang-Lun Z. A highly sensitive electrochemiluminescence immunoassay for detecting human embryonic human chorionic gonadotropin in spent embryo culture media during IVF-ET cycle. J Assist Reprod Genet. 2013;30(3):377–82.CrossRefPubMed
29.
Zurück zum Zitat Wang H, Zhang R, Han D, Liu C, Cai J, Bi Y, et al. Association of human chorionic gonadotropin level in embryo culture media with early embryo development. Nan Fang Yi Ke Da Xue Xue Bao. 2014;34(7):1039–41 1047.PubMed Wang H, Zhang R, Han D, Liu C, Cai J, Bi Y, et al. Association of human chorionic gonadotropin level in embryo culture media with early embryo development. Nan Fang Yi Ke Da Xue Xue Bao. 2014;34(7):1039–41 1047.PubMed
30.
Zurück zum Zitat Parvanov D, Nikolova D, Ganeva R, Nikolova K, Vasileva M, Rangelov I, et al. Maternal age and blastocyst quality do not influence the embryo production of hyperglycosylated human chorionic gonadotropin. Fertil Steril. 2019;112(3):e130.CrossRef Parvanov D, Nikolova D, Ganeva R, Nikolova K, Vasileva M, Rangelov I, et al. Maternal age and blastocyst quality do not influence the embryo production of hyperglycosylated human chorionic gonadotropin. Fertil Steril. 2019;112(3):e130.CrossRef
31.
Zurück zum Zitat Stamenov G, Nikolova K, Vasileva M, Rangelov I, Ganeva R, Pancheva M, et al. Hyperglycosylated human chorionic gonadotropin in blastocyst culture medium of male and female human embryos. Fertil Steril. 2019;112(3):e126.CrossRef Stamenov G, Nikolova K, Vasileva M, Rangelov I, Ganeva R, Pancheva M, et al. Hyperglycosylated human chorionic gonadotropin in blastocyst culture medium of male and female human embryos. Fertil Steril. 2019;112(3):e126.CrossRef
32.
Zurück zum Zitat McCallie BR, Parks JC, Denomme Tignanelli M, Schoolcraft WB, Katz-Jaffe M. RNA sequencing of aneuploid blastocysts revealed enriched pathways associated with compromised implantation potential. Fertil Steril. 2016;106(3):е23.CrossRef McCallie BR, Parks JC, Denomme Tignanelli M, Schoolcraft WB, Katz-Jaffe M. RNA sequencing of aneuploid blastocysts revealed enriched pathways associated with compromised implantation potential. Fertil Steril. 2016;106(3):е23.CrossRef
33.
Zurück zum Zitat Spencer K. Evaluation of an assay of the free beta-subunit of choriogonadotropin and its potential value in screening for Down's syndrome. Clin Chem. 1991;37:809–14.CrossRefPubMed Spencer K. Evaluation of an assay of the free beta-subunit of choriogonadotropin and its potential value in screening for Down's syndrome. Clin Chem. 1991;37:809–14.CrossRefPubMed
34.
Zurück zum Zitat Spencer K, Macri JN, Aitken DA, Connor JM. Free beta-hCG as first-trimester marker for fetal trisomy. Lancet. 1992;339:1480.CrossRefPubMed Spencer K, Macri JN, Aitken DA, Connor JM. Free beta-hCG as first-trimester marker for fetal trisomy. Lancet. 1992;339:1480.CrossRefPubMed
35.
Zurück zum Zitat Bogart MH, Pandian MR, Jones OW. Abnormal maternal serum chorionic gonadotropin levels in pregnancies with fetal chromosome abnormalities. Prenat Diagn. 1987;7:623–30.CrossRefPubMed Bogart MH, Pandian MR, Jones OW. Abnormal maternal serum chorionic gonadotropin levels in pregnancies with fetal chromosome abnormalities. Prenat Diagn. 1987;7:623–30.CrossRefPubMed
36.
Zurück zum Zitat Bindra R, Liao VHA, Spencer K, Nicolaides KH. One stop clinic for assessment of risk for trisomy 21 at 11–14 weeks: a prospective study of 15030 pregnancies. Ultrasound Obstet Gynecol. 2002;20:219–25.CrossRefPubMed Bindra R, Liao VHA, Spencer K, Nicolaides KH. One stop clinic for assessment of risk for trisomy 21 at 11–14 weeks: a prospective study of 15030 pregnancies. Ultrasound Obstet Gynecol. 2002;20:219–25.CrossRefPubMed
37.
Zurück zum Zitat Bernd E. Glaubitz Ralf. First-trimester screening: an overview. J Histochem Cytochem. 2005;53(3):281–3.CrossRef Bernd E. Glaubitz Ralf. First-trimester screening: an overview. J Histochem Cytochem. 2005;53(3):281–3.CrossRef
38.
Zurück zum Zitat Cole LA, Dai D, Butler SA, Leslie KK, Kohorn EI. Gestational trophoblastic diseases: 1. Pathophysiology of hyperglycosylated hCG. Gynecol Oncol. 2006;102:144–9. Cole LA, Dai D, Butler SA, Leslie KK, Kohorn EI. Gestational trophoblastic diseases: 1. Pathophysiology of hyperglycosylated hCG. Gynecol Oncol. 2006;102:144–9.
39.
Zurück zum Zitat Cole LA, Khanlian SA, Riley JM, Butler SA. Hyperglycosylated hCG in gestational implantation and in choriocarcinoma and testicular germ cell malignancy tumorigenesis. J Reprod Med. 2006;51:919–29.PubMed Cole LA, Khanlian SA, Riley JM, Butler SA. Hyperglycosylated hCG in gestational implantation and in choriocarcinoma and testicular germ cell malignancy tumorigenesis. J Reprod Med. 2006;51:919–29.PubMed
Metadaten
Titel
Unbalanced human embryos secrete more hyperglycosylated human chorionic gonadotrophin (hCG-H) than balanced ones
verfasst von
Dimitar Parvanov
Dragomira Nikolova
Rumiana Ganeva
Kristina Nikolova
Magdalena Vasileva
Ivaylo Rangelov
Maria Pancheva
Maria Serafimova
Rada Staneva
Savina Hadjidekova
Fabio Scarpellini
Georgi Stamenov
Publikationsdatum
22.04.2020
Verlag
Springer US
Erschienen in
Journal of Assisted Reproduction and Genetics / Ausgabe 6/2020
Print ISSN: 1058-0468
Elektronische ISSN: 1573-7330
DOI
https://doi.org/10.1007/s10815-020-01776-9

Weitere Artikel der Ausgabe 6/2020

Journal of Assisted Reproduction and Genetics 6/2020 Zur Ausgabe

Alter verschlechtert Prognose bei Endometriumkarzinom

11.05.2024 Endometriumkarzinom Nachrichten

Ein höheres Alter bei der Diagnose eines Endometriumkarzinoms ist mit aggressiveren Tumorcharakteristika assoziiert, scheint aber auch unabhängig von bekannten Risikofaktoren die Prognose der Erkrankung zu verschlimmern.

Darf man die Behandlung eines Neonazis ablehnen?

08.05.2024 Gesellschaft Nachrichten

In einer Leseranfrage in der Zeitschrift Journal of the American Academy of Dermatology möchte ein anonymer Dermatologe bzw. eine anonyme Dermatologin wissen, ob er oder sie einen Patienten behandeln muss, der eine rassistische Tätowierung trägt.

Erhöhte Mortalität bei postpartalem Brustkrebs

07.05.2024 Mammakarzinom Nachrichten

Auch für Trägerinnen von BRCA-Varianten gilt: Erkranken sie fünf bis zehn Jahre nach der letzten Schwangerschaft an Brustkrebs, ist das Sterberisiko besonders hoch.

Menopausale Hormontherapie für Frauen über 65?

07.05.2024 Klimakterium und Menopause Nachrichten

In den USA erhalten nicht wenige Frauen auch noch im Alter über 65 eine menopausale Hormontherapie. Welche positiven und negativen gesundheitlichen Konsequenzen daraus möglicherweise resultieren, wurde anhand von Versicherungsdaten analysiert.

Update Gynäkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.